These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34497774)

  • 21. Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():694036. PubMed ID: 34041039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cell subsets and immunological milieu in inflammatory human papilloma virus-related skin lesions.
    Nakayama Y; Asagoe K; Yamauchi A; Yamamoto T; Shirafuji Y; Morizane S; Nakanishi G; Iwatsuki K
    J Dermatol Sci; 2011 Sep; 63(3):173-83. PubMed ID: 21715145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells.
    Schutyser E; Struyf S; Menten P; Lenaerts JP; Conings R; Put W; Wuyts A; Proost P; Van Damme J
    J Immunol; 2000 Oct; 165(8):4470-7. PubMed ID: 11035086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines.
    Chabaud M; Page G; Miossec P
    J Immunol; 2001 Nov; 167(10):6015-20. PubMed ID: 11698482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retraction: LINC00337 Regulates KLF5 and Maintains Stem-Cell Like Traits of Cervical Cancer Cells by Modulating miR-145.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840051. PubMed ID: 35036358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retraction: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():839904. PubMed ID: 35036357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity.
    Izadpanah A; Dwinell MB; Eckmann L; Varki NM; Kagnoff MF
    Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G710-9. PubMed ID: 11254498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retraction: OTUB2 facilitates tumorigenesis of gastric cancer through promoting KDM1A-mediated stem cell-like properties.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1209867. PubMed ID: 37287909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retraction: RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway.
    Frontiers Editorial Office
    Front Oncol; 2020; 10():607586. PubMed ID: 33194774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19.
    Scapini P; Laudanna C; Pinardi C; Allavena P; Mantovani A; Sozzani S; Cassatella MA
    Eur J Immunol; 2001 Jul; 31(7):1981-8. PubMed ID: 11449350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
    Giuliani N; Lisignoli G; Colla S; Lazzaretti M; Storti P; Mancini C; Bonomini S; Manferdini C; Codeluppi K; Facchini A; Rizzoli V
    Cancer Res; 2008 Aug; 68(16):6840-50. PubMed ID: 18703490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors.
    Dieu-Nosjean MC; Massacrier C; Homey B; Vanbervliet B; Pin JJ; Vicari A; Lebecque S; Dezutter-Dambuyant C; Schmitt D; Zlotnik A; Caux C
    J Exp Med; 2000 Sep; 192(5):705-18. PubMed ID: 10974036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retraction: Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells
    Frontiers Editorial Office
    Front Oncol; 2021; 11():759578. PubMed ID: 34557421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retraction: CDX2/mir-145-5p/SENP1 Pathways Affect LNCaP Cells Invasion and Migration.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():744978. PubMed ID: 34490129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity.
    Bonnotte B; Crittenden M; Larmonier N; Gough M; Vile RG
    J Immunol; 2004 Oct; 173(8):4929-35. PubMed ID: 15470034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retraction Notice to: Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment.
    Xiong H; Chen Z; Lin B; Chen W; Li Q; Li Y; Fang M; Wang Y; Zhang H; Lu Y; Bi A; Wu S; Jia Y; Wang X
    Mol Ther Oncolytics; 2022 Jun; 25():263. PubMed ID: 35615267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retraction: Corrigendum: CDX2/mir-145-5p/SENP1 Pathways Affect LNCaP Cells Invasion and Migration.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():744980. PubMed ID: 34490130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter.
    Reibman J; Hsu Y; Chen LC; Bleck B; Gordon T
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):648-54. PubMed ID: 12760962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microencapsulation of tumor lysates and live cell engineering with MIP-3α as an effective vaccine.
    Huang FY; Huang FR; Chen B; Liu Q; Wang H; Zhou SL; Zhao HG; Huang YH; Lin YY; Tan GH
    Biomaterials; 2015; 53():554-65. PubMed ID: 25890751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1285219. PubMed ID: 37731635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.